Elevra puts North American lithium growth into motion with 373ktpa NAL target

NAL expansion sets the growth agenda

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) is selling investors a larger North American lithium platform, with its 100%-owned North American Lithium operation in Québec at the centre. A three-stage brownfield expansion is designed to lift average annual spodumene concentrate capacity from about 199,000 tonnes to 373,000 tonnes, with total initial capital estimated at US$271 million.

The plan starts with mill optimisation, adding about 35,000 tonnes a year for an estimated US$68 million. A second stage would lift milling throughput from 4,500 tonnes per day to 6,500 tonnes per day and take average production to about 338,000 tonnes, while the final stage adds permanent crushing and ore-sorting infrastructure to reach the 373,000-tonne target. Elevra says the staged approach is intended to lower unit costs and use existing infrastructure, but the proposed mid-2027, mid-2028 and mid-2029 timing remains indicative.

FY27 guidance points to higher spending first

The near-term outlook is more measured than the long-term expansion headline. Elevra expects FY27 production of 198,000-210,000 dry metric tonnes and sales of 200,000-230,000 tonnes, based on a 5.2% spodumene concentrate grade. Unit operating costs are forecast at US$880-US$950 per tonne sold, above FY26's US$853, with the company citing inflation, foreign exchange, a higher strip ratio and pre-strip work ahead of the expansion.

Capital expenditure is expected to rise from FY26's US$24 million to US$120-US$140 million. About US$100-US$120 million is allocated to the NAL expansion and Moblan studies, with a further US$20 million for sustaining capital at NAL. That spending profile makes delivery, rather than merely announcing capacity, the immediate test for the strategy.

Operating base provides room to scale

FY26 revenue rose to US$202 million, while cash at 30 June stood at US$255 million. NAL produced 197,967 dry metric tonnes, only 3% below the previous year despite temporary mining constraints, and recovery improved to 71% in the fourth quarter. Mill utilisation remained high, although full-year recovery was 67% and the reported cost base increased as mining activity intensified.

Elevra says the operation's established production platform, improving safety performance and consistent mill utilisation reduce execution risk as capacity expands. That is a company assessment rather than a guarantee: the expansion still depends on engineering, procurement, construction and additional approvals for later stages.

Moblan remains the second growth lever

The 60%-owned Moblan project in Québec is being reassessed after substantial growth in its mineral resource and ore reserve base. Elevra plans an updated definitive feasibility study, with an updated scoping study due in Q4 CY26, focused on the appropriate development scale and capital intensity. The project is described as funded for pre-development work through to a final investment decision, but no final investment decision or construction commitment is announced in this presentation.

Carolina Lithium in North Carolina remains a fully integrated mine-to-chemical option, while Authier adds another Québec development asset. Elevra is also seeking a more diversified, market-linked sales portfolio as NAL volumes grow, including offtake agreements and strategic partnerships across Québec and the United States. The presentation's broker consensus assumes spodumene concentrate prices average US$2,466 a tonne in 2026 before easing to US$1,729 by 2030, while lithium demand is forecast to rise from 1.887 million tonnes of lithium carbonate equivalent to 3.047 million tonnes over the same period.